A psychostimulant is a drug that increases activity in the central nervous system, boosting alertness, attention, and energy. The term covers a wide range of substances, from prescription medications used to treat ADHD to illegal drugs like methamphetamine and cocaine, and even everyday substances like caffeine. What ties them together is their shared ability to ramp up signaling between brain cells, particularly in the pathways that use dopamine and norepinephrine.
How Psychostimulants Work in the Brain
Despite their differences in potency and legality, most psychostimulants converge on the same basic target: the dopamine system. Dopamine is the brain’s primary chemical messenger for motivation, reward, and focus. Normally, after a nerve cell releases dopamine into the gap between neurons, a transporter protein pulls it back in for recycling. Psychostimulants interfere with that recycling process, leaving more dopamine active in the gap for longer.
The two most common prescription stimulants illustrate this well. Methylphenidate (the active ingredient in Ritalin and Concerta) blocks the dopamine transporter so dopamine can’t be pulled back into the nerve cell. Amphetamine (the active ingredient in Adderall and Dexedrine) does the same thing, but it also forces extra dopamine out of the nerve cell and into the gap. The result is the same: more dopamine signaling, which translates to sharper focus and increased wakefulness.
Cocaine works similarly to methylphenidate, blocking the dopamine transporter, but it hits harder and faster because of how quickly it reaches the brain when snorted or smoked. Caffeine takes a completely different route. Instead of targeting dopamine directly, it blocks receptors for adenosine, a chemical that builds up throughout the day and makes you feel sleepy. By blocking adenosine, caffeine indirectly promotes alertness. Nicotine activates a specific type of receptor that triggers dopamine release downstream, which is why smoking feels stimulating even though it works through a different mechanism than prescription stimulants.
What Psychostimulants Are Prescribed For
Prescription psychostimulants are FDA-approved for three main conditions: ADHD, narcolepsy, and binge-eating disorder. In ADHD, they help reduce impulsivity and hyperactivity while improving the ability to focus, listen, and stay on task. For narcolepsy, they promote wakefulness during the day. For binge-eating disorder, they help reduce the frequency of excessive overeating episodes.
A related but distinct stimulant, modafinil, is prescribed specifically for sleep disorders like narcolepsy, obstructive sleep apnea, and shift-work sleep disorder. It promotes wakefulness through a different mechanism than amphetamines and carries a lower risk of abuse.
Common Prescription Psychostimulants
The two major classes prescribed in the United States are methylphenidate-based and amphetamine-based medications. Methylphenidate is sold under brand names including Ritalin, Concerta, Aptensio XR, Jornay PM, and Quillivant XR. These come in short-acting forms taken two or three times a day and long-acting forms taken once daily. Amphetamine-based options include Adderall, Dexedrine, and Vyvanse.
Both classes are classified as Schedule II controlled substances by the DEA, the same category as oxycodone and fentanyl. This reflects their recognized medical value alongside a high potential for misuse and dependence. Some milder stimulants, like benzphetamine, fall under Schedule III, indicating a lower abuse risk.
Non-Prescription and Illegal Stimulants
The psychostimulant category extends well beyond the pharmacy. Caffeine is the most widely used stimulant in the world and is unregulated. Nicotine, found in tobacco and vaping products, also has stimulant properties. Pseudoephedrine, an over-the-counter nasal decongestant, belongs to the amphetamine drug class and has mild stimulant effects.
On the illegal end of the spectrum, cocaine, methamphetamine, and MDMA (ecstasy) are all psychostimulants. Khat, a flowering plant chewed in parts of East Africa and the Arabian Peninsula, contains cathinone, a compound chemically related to amphetamine. It is banned in the United States. Synthetic cathinones, sometimes called “bath salts,” are newer designer drugs derived from the same chemical family.
Side Effects and Cardiovascular Risks
The most common side effects of prescription psychostimulants include decreased appetite, trouble sleeping, dry mouth, and feeling jittery or anxious. These tend to be most noticeable when starting a new medication or increasing the dose.
The cardiovascular effects get more attention. A meta-analysis of over 2,600 adult patients found that prescription stimulants raised resting heart rate by an average of 5.7 beats per minute and systolic blood pressure by about 1.2 mmHg. Another study found slightly larger blood pressure increases, around 5 mmHg systolic and 7 mmHg diastolic. For most healthy adults, these changes are modest. The overall risk of a clinically significant cardiovascular event like dangerously fast heart rate or high blood pressure was 5% or lower.
The picture changes for people with existing heart conditions. A study of over 1,200 children found that stimulant use increased the risk of arrhythmias, with the highest risk in children who already had congenital heart disease. The risk of heart attack was elevated in the first 8 to 56 days after starting methylphenidate, though the overall risk across all time periods was not statistically significant. No increased risk was found for stroke or heart failure.
Dependence and Addiction Risk
Psychostimulants carry a real risk of dependence, particularly when used at high doses, taken in ways other than prescribed (snorting or injecting), or used recreationally. Dependence develops as the brain adapts to consistently elevated dopamine levels. Over time, the brain’s natural dopamine system downregulates, meaning it produces or responds to less dopamine on its own. This creates tolerance (needing more to get the same effect) and withdrawal symptoms like fatigue, depression, and intense cravings when the drug is stopped.
Modern neuroscience increasingly frames stimulant addiction as a brain disorder involving changes in learning and memory circuits rather than simply a matter of willpower. Brain imaging studies have mapped specific changes in how neural circuits reorganize themselves during chronic stimulant use, helping explain why relapse rates are high and why quitting is so difficult even when someone genuinely wants to stop.
Prescription use at therapeutic doses for conditions like ADHD carries a much lower addiction risk than recreational use, in part because oral medications are absorbed slowly and produce a gradual rise in dopamine rather than the sharp spike associated with snorting cocaine or smoking methamphetamine. That spike is what makes the brain strongly associate the drug with reward.
Long-Term Effects on the Brain
For people taking prescription stimulants for ADHD, the long-term brain effects appear to be subtle and, in some cases, potentially beneficial. A brain imaging study comparing adults with ADHD who had been on stimulant treatment to those who had never taken medication found measurable differences in brain surface structure. The treated group showed higher values in metrics related to the folding patterns and complexity of the brain’s outer layer, particularly in regions involved in motor planning, sensory processing, and decision-making. However, the study found limited effects on overall ADHD symptom scores and total grey matter volume in adults, suggesting that structural brain changes don’t always translate directly into dramatic clinical improvements.
The long-term effects of recreational or high-dose stimulant use are far less favorable. Chronic cocaine and methamphetamine use is associated with inflammation in the brain, reduced dopamine receptor availability, and cognitive deficits in areas like impulse control and decision-making. These changes can persist for months or years after someone stops using, though some degree of recovery does occur over time.